Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Biotech
Third Rock, Novo Holdings-backed Clasp hooks $150M series A
A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-gen T cell engagers.
Gabrielle Masson
Mar 20, 2024 7:00am
Next-gen PSA test maker Cleveland Dx rocks to $75M fundraising
Jan 29, 2024 11:07am
Novo Holdings plans to ramp up dealmaking amid Wegovy windfall
Jan 19, 2024 9:30am
Miniature neurostimulator developer Nalu Medical nets $65M
Jan 4, 2024 11:16am
Novo Nordisk Foundation sets up $260M vaccine initiative
Dec 18, 2023 11:14am
Novo Nordisk's owner widens investment strategy beyond biotech
Oct 6, 2023 9:55am